In health news, India has cleared Takeda’s QDENGA, the country’s first dengue vaccine, a notable step for a nation facing a heavy and growing mosquito-borne disease burden driven by urbanisation, climate pressures, and recurring outbreaks. The two-dose shot, approved for people aged 4 to 60, is designed to protect against all four dengue strains and can be given without prior screening, potentially simplifying rollout if supply, pricing, and distribution fall into place. The approval comes as public health systems worldwide are under pressure to expand prevention rather than simply respond to seasonal surges. Elsewhere, a deadly river incident near Columbus, Ohio, underscored the human cost of emergencies unfolding in seconds, after five people died trying to rescue a struggling swimmer — a stark reminder that public safety and rapid-response preparedness remain vital parts of the broader health picture.